Suan Farma Holding, S.L.
Climate Impact & Sustainability Data (2022, 2023)
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Environment
- Social
- Governance
Environmental Achievements
- Reduced water consumption by 45.59%
- Reduced waste generation by 10%
- Increased renewable energy share by 5%
Social Achievements
- Implemented a satisfaction survey with 75.52% participation and an average score of 7.46/10
- Low number of layoffs (1.55% of workforce)
- Provided training to 339 people at Fundación Arraigo
- 23 interns provided opportunities at facilities in Spain, Portugal, Italy, and Mexico
- Nine internal promotions
Governance Achievements
- Established a robust framework of policies and protocols, including a Code of Ethics and Conduct, an anti-corruption policy, and a protocol for accepting gifts and hospitality
- Implemented a whistle-blowing channel
- No complaints received for human rights violations
Climate Goals & Targets
- Development of a long-term strategy to reduce GHG emissions
- Not disclosed
- Not disclosed
Environmental Challenges
- Increased consumption of resources due to greater productive activity
- Managing waste generated in operations
Mitigation Strategies
- Implemented innovative practices and technologies to optimize water use
- Implemented projects focused on reducing raw material use
- Implemented water distillation process to recover solvents
- Implemented procedures for cleaning and reusing packaging
- Implemented various measures to reduce greenhouse gas emissions (e.g., gaseous emissions treatment systems, condensers for solvent VOCs, use of compliant refrigerant gases)
Supply Chain Management
Supplier Audits: 7 audits (4 industrial, 3 nutraceutical)
Responsible Procurement
- Code of Conduct for Suppliers
- Preference for local suppliers for packaging and general services
- Additional safeguards for suppliers in at-risk countries
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: null
Certifications: ISO 14001 (Spain, Portugal, Italy)
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- SDG 3 (Good health and well-being)
- SDG 8 (Decent work and economic growth)
- SDG 9 (Industry, innovation and infrastructure)
- SDG 12 (Responsible consumption and production)
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Environment
- Social
- Governance
Environmental Achievements
- Implemented measures to reduce greenhouse gas emissions; initiated projects to implement gas emission treatment systems at Cipan and odour emission monitoring plan at Rovereto; implemented projects to reduce the use of raw materials; implemented procedures for cleaning and reusing packaging materials; ongoing project to reuse methanol at Cipan; installed a new ethanol distillation and recovery plant at Rovereto reducing ethanol consumption by 90%; implemented improvements to the cooling efficiency of fermenters at Rovereto.
- Reduced water consumption through various measures including more efficient equipment washing processes at Cipan and installation of closed-loop vacuum pump cooling systems at Rovereto.
Social Achievements
- Launched employee satisfaction survey; implemented a comprehensive harassment protocol; implemented a ‘Talent School’ program for young graduates; collaborated with Children’s Vaccination Alliance; fostered a culture of work-life balance and flexible work arrangements; implemented training programs with a significant increase in training hours in 2023; maintained a low number of work accidents and no occupational diseases.
Governance Achievements
- Defined a risk map in 2022, identifying and analyzing main risks; implemented a Code of Ethics and Conduct; implemented a Human Rights Policy; established a whistleblowing channel; approved an Internal Whistleblowing System Policy; implemented an anti-bribery and corruption policy; created and approved the ‘Supplier Code of Conduct’ in 2021; conducted regular supplier audits (12 in 2023); implemented a Quality, Safety and Environment Management System (QSE) at Cipan.
Climate Goals & Targets
- Long-term strategy to reduce greenhouse gas emissions (Rovereto).
- Not disclosed
- Conduct an analysis of greenhouse gas emissions by 2024 and set medium-term reduction targets.
Environmental Challenges
- Increased energy consumption due to increased production; exceeding maximum volume of water captured and discharged at Cipan in 2022; managing risks related to economic-financial matters, data management, stakeholder management, environmental, chemical-bacteriological risks regarding products, and regulatory compliance.
Mitigation Strategies
- Implemented several measures to reduce greenhouse gas emissions and working on a medium- and long-term strategy; implemented gas emission treatment systems and odour emission monitoring; implemented projects to reduce raw material use and improve energy efficiency; implemented water saving measures; implemented a risk management strategy to address identified risks.
Supply Chain Management
Supplier Audits: 12/year
Responsible Procurement
- Supplier Code of Conduct (2021), including aspects of workers’ rights, health and safety, ethics, anti-corruption, and environmental, social and economic impacts.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: GRI Sustainability Standards Reporting (Essential version)
Certifications: ISO 14001 (Rovereto), ISO 45001 (Rovereto), EMAS III Regulation (Rovereto), UNI 10617 (Rovereto), UNI EN ISO 50001 (Rovereto), ISO 14001 (Cipan)
Third-party Assurance: PwC
UN Sustainable Development Goals
- Goal 3 (Good Health and Well-being)
- Goal 4 (Quality Education)
- Goal 5 (Gender Equality)
- Goal 8 (Decent Work and Economic Growth)
- Goal 9 (Industry, Innovation and Infrastructure)
- Goal 12 (Responsible Consumption and Production)
- Goal 13 (Climate Action)
- Goal 16 (Peace, Justice and Strong Institutions)
Suanfarma's activities contribute to these goals through its production of affordable generic medicines, commitment to employee training and development, promotion of gender equality, responsible business practices, investment in innovation, sustainable resource management, climate action initiatives, and ethical conduct.